Seattle Genetics is the first pick of this experiment

With the symbol of SGEN, Seattle Genetics will be the first stock pick for the up coming workshop. Today it traded at $11.73 and if it can trade down to the $11.00 to $11.25 area we will look for a "Base System" buy trigger.

Seattle Genetics, Inc. (Nasdaq:SGEN) announced on July 31, 2008 that it has initiated a phase I clinical trial of SGN-70, a humanized monoclonal antibody targeting CD70 that is being developed as an investigational therapy for autoimmune diseases. The trial will assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers. CD70 is also expressed on several types of cancer, including multiple myeloma, lymphoma, renal cell cancer, glioblastoma and several other solid tumors. In addition to SGN-70, Seattle Genetics is advancing SGN-75, an antibody-drug conjugate targeting CD70, for the treatment of cancer and expects to file an investigational new drug (IND) application in 2009.

Now of course, only a fool would just buy this because you read something on the internet or in a blog about it. But follow along over the next several weeks as we move toward the workshop. I want to make sure that you know that these picks are not in hindsight...cherry pickin...crapola. At this workshop, I will show how I find these picks, how I determine which ones could be used for a trade, how I setup the trade and then how I trigger into the trade....also what am I looking for in profits......

This workshop is for anyone that wants to understand how to trade without depending upon your barber, the paperboy, mother-in-law or for heaven sake......MARIA.....:)